No Data
No Data
CGN Nuclear Technology Development (SZSE:000881) Is Carrying A Fair Bit Of Debt
cgn nuclear technology development (000881.SZ): The industrial fund in which the company participates has completed the record filing for private equity funds.
On September 19, Glorious Times reported that CGN Nuclear Technology (000881.SZ) announced that the company recently received a notice from CGN Industrial Investment Fund Management Co., Ltd., the fund manager, that the company participated in the establishment of the Mianyang Egret nuclear technology equity investment fund partnership enterprise (limited partnership) initiated by the Mianyang Municipal Government, has completed the record filing with the China Securities Investment Fund Association.
cgn nuclear technology development (000881.SZ): Our first proton therapy equipment is expected to be offline around October of this year.
格隆汇September 18th | cgn nuclear technology development (000881.SZ) stated on the investor interaction platform that the device Histotripsy mentioned by investors is an innovative non-invasive treatment technology based on high-intensity focused ultrasound (HIFU). Unlike traditional cancer treatment methods such as surgical resection, radiotherapy, and chemotherapy, Histotripsy uses extracorporeal focused ultrasound to destroy tumor tissue by utilizing the acoustic cavitation effect. This device has different application scenarios and applicable patients in clinical practice compared to the proton therapy equipment produced by our company. The first proton therapy equipment from our company is expected to be launched in October this year.
CGN Nuclear Technology Development (000881.SZ): Some production lines in the new materials business sector use automatic packaging and stacking systems.
On September 18th, CGN Nuclear Technology Development (000881.SZ) stated on the investor interaction platform that some production lines in the company's new materials sector are using automatic packaging and stacking systems. In the future, the company will continuously improve the level of automation and intelligence in production and manufacturing according to the needs of business development.
cgn nuclear technology development (000881.SZ): The silicon photomultiplier detectors being produced by Zhongjing Optoelectronics are not suitable for use in HEPS.
cgn nuclear technology development (000881.SZ) stated on the investor interaction platform on September 18 that the silicon photomultiplier detector being produced by Zhongjing Optoelectronics cannot be used in HEPS.
cgn nuclear technology development(000881.SZ): At present, no new proton equipment contracts have been signed.
Cgn nuclear technology development (000881.SZ) stated on the investor interaction platform on September 18 that it has not yet signed any new contracts for proton equipment. The company has been actively seeking new orders, but the development cycle of proton therapy projects is relatively long, and it is influenced by the actual progress of hospital project bidding and market competition. Currently, several projects that our company is closely monitoring are still in the project development phase.
No Data
No Data